Gilead Sciences (GILD) Numbers Go Higher at Nomura on HCV

February 4, 2014 7:56 AM

Nomura Securities analyst M. Ian Somaiya reiterated a Buy rating and raised his price target on Gilead Sciences (NASDAQ: GILD) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found